Genetic_NP and_CC Biochemical_NP Characterization_NP of_IN CGB-1_NP ,_, an_DT Ambler_NP Class_NP B_NP Carbapenem-Hydrolyzing_NP beta-Lactamase_NN from_IN Chryseobacterium_NN gleum_NN Chryseobacterium_NN gleum_NN (_( previously_RB included_VBN in_IN the_DT Flavobacterium_NP IIb_NP species_NN )_) is_VBZ a_DT gram-negative_JJ aerobe_NN that_WDT is_VBZ a_DT source_NN of_IN nosocomial_JJ infections_NNS ._SENT An_DT Ambler_NP class_NN B_NP beta-lactamase_NN gene_NN was_VBD cloned_VBN and_CC expressed_VBN in_IN Escherichia_NP coli_NNS from_IN reference_NN strain_NN C._NP gleum_NN CIP_NP 103039_CD that_WDT had_VBD reduced_VBN susceptibility_NN to_TO expanded-spectrum_NN cephalosporins_NNS and_CC carbapenems_NNS ._SENT The_DT purified_VBN beta-lactamase_NN ,_, CGB-1_NP ,_, with_IN a_DT pI_NN value_NN of_IN 8.6_CD and_CC a_DT determined_VBN relative_JJ molecular_JJ mass_NN of_IN ca_MD ._SENT 26_CD kDa_NN ,_, hydrolyzed_VBN penicillins_NNS ;_: narrow-_NN and_CC expanded-spectrum_NN cephalosporins_NNS ;_: and_CC carbapenems_NNS ._SENT CGB-1_NP was_VBD a_DT novel_JJ member_NN of_IN the_DT molecular_JJ subclass_NN B1_NN of_IN metallo-enzymes_NNS ._SENT It_PP had_VBD 83_CD and_CC 42_CD %_NN amino_NN acid_JJ identity_NN with_IN IND-1_NP from_IN Chryseobacterium_NP indologenes_NP and_CC BlaB_NP from_IN C._NP meningosepticum_NN ,_, respectively_RB ._SENT Thus_RB ,_, in_IN addition_NN to_TO the_DT previously_RB characterized_VBN clavulanic_JJ acid-inhibited_JJ extended-spectrum_NN beta-lactamase_NN CGA-1_NP of_IN Ambler_NP class_NN A_NP ,_, C._NP gleum_NP produces_VBZ a_DT very_RB likely_JJ chromosome-borne_JJ class_NN B_NN beta-lactamase_NN ._SENT Metallo-beta-lactamases_NNS of_IN Ambler_NP class_NN B_NN are_VBP zinc-dependent_JJ enzymes_NNS that_WDT possess_VBP the_DT property_NN of_IN hydrolyzing_VBG most_RBS beta-lactam_JJ antibiotics_NNS ,_, including_VBG carbapenems_NNS ._SENT Some_DT of_IN these_DT enzymes_NNS are_VBP emerging_VBG worldwide_RB in_IN gram-negative_JJ pathogens_NNS as_IN a_DT result_NN of_IN plasmid-_NN and_CC integron-location_NN of_IN their_PP$ genes_NNS that_WDT are_VBP of_IN the_DT blaIMP_NN and_CC blaVIM_NN series_NN ._SENT However_RB ,_, several_JJ metallo-beta-lactamases_NNS have_VBP been_VBN reported_VBN as_IN a_DT source_NN of_IN intrinsic_JJ resistance_NN to_TO carbapenems_NNS in_IN bacterial_JJ species_NNS less_RBR frequently_RB isolated_VBN in_IN clinical_JJ microbiology_NN ,_, such_JJ as_IN L-1_NP from_IN Stenotrophomonas_NP maltophilia_NP ,_, Bc-II_NP from_IN Bacillus_NN cereus_NN 569/H_NP ,_, CcrA_NP from_IN Bacteroides_NP fragilis_NP ,_, CphA_NP from_IN Aeromonas_NP hydrophila_NP ,_, FEZ-1_NP from_IN Legionella_NP gormanii_NNS ,_, ,_, and_CC THIN-B_NP from_IN Janthinobacterium_NP lividum_NN ._SENT Flavobacteria_NN species_NNS are_VBP mostly_RB a_DT source_NN of_IN nosocomial_JJ infections_NNS ._SENT Metallo-beta-lactamases_NNS have_VBP been_VBN identified_VBN so_RB far_RB in_IN two_CD Flavobacterium_NN species_NNS ,_, Chryseobacterium_NN meningosepticum_NN and_CC Chryseobacterium_NN indologenes_NNS ._SENT C._NP meningosepticum_NP usually_RB expresses_VBZ two_CD unrelated_JJ metallo-enzymes_NNS of_IN the_DT BlaB_NP and_CC GOB-like_JJ series_NNS that_WDT share_VBP less_JJR than_IN 12_CD %_NN amino_NN acid_NN identity_NN ._SENT C._NP indologenes_NNS expresses_VBZ IND-like_JJ enzymes_NNS that_WDT share_VBP less_JJR than_IN 45_CD and_CC 15_CD %_NN amino_NN acid_JJ identity_NN with_IN BlaB_NP and_CC GOB-like_JJ enzymes_NNS ,_, respectively_RB ._SENT A_DT search_NN for_IN a_DT potential_JJ natural_JJ reservoir_NN of_IN acquired_VBN carbapenem-hydrolyzing_NN beta-lactamases_NNS is_VBZ interesting_JJ ,_, particularly_RB in_IN understanding_VBG the_DT mechanism(s)_NN of_IN integration_NN of_IN these_DT genes_NNS in_IN an_DT integron_NN ._SENT Thus_RB ,_, we_PP proceeded_VBD to_TO study_VB the_DT beta-lactamase_NN content_NN of_IN another_DT Flavobacterium_NP species_NN ,_, Chryseobacterium_NN gleum_NN that_WDT is_VBZ a_DT phylogenetically_RB related_VBN species_NNS to_TO C._NP indologenes_NNS ._SENT From_IN C._NP gleum_NN strain_NN CIP_NP 103039_CD ,_, we_PP have_VBP reported_VBN a_DT clavulanic-acid_NN inhibited_VBN Ambler_NP class_NN A_DT expanded-spectrum_NN beta-lactamase_NN (_( ESbetaL_NP )_) ,_, CGA-1_NP ._SENT However_RB ,_, since_IN C._NP gleum_NN CIP_NP 103039_CD had_VBD also_RB reduced_VBN susceptibility_NN to_TO carbapenems_NNS and_CC CGA-1_NP hydrolyzes_VBZ weakly_RB these_DT beta-lactam_NN group_NN ,_, the_DT aim_NN of_IN our_PP$ study_NN was_VBD to_TO analyze_VB the_DT mechanism_NN sustaining_VBG carbapenem_NN resistance_NN in_IN C._NP gleum_NN ._SENT We_PP have_VBP cloned_VBN and_CC identified_VBN genetically_RB and_CC biochemically_RB a_DT novel_NN metallo-beta-lactamase_NN that_WDT is_VBZ closely_RB related_VBN to_TO metallo-enzymes_NNS of_IN C._NP indologenes_NNS ._SENT Bacterial_JJ strains_NNS ._SENT |_SYM C._NP gleum_NN reference_NN strain_NN CIP_NP 103039_CD was_VBD from_IN the_DT Institut_NP Pasteur_NP Collection_NP ._SENT Escherichia_NP coli_NNS DH10B_NP and_CC nalidixic_JJ acid-resistant_JJ E._NP coli_NNS JM109_NP were_VBD used_VBN for_IN cloning_VBG and_CC conjugation_NN assays_NNS ,_, respectively_RB ._SENT All_DT strains_NNS were_VBD stored_VBN at_IN -70C_NN in_IN Trypticase_NP soy_NN (_( TS_NP )_) broth_NN (_( Becton_NP Dickinson_NP ,_, Le_NP Pont-de-Claix_NP ,_, France_NP )_) supplemented_VBD with_IN 15_CD %_NN glycerol_NN until_IN testing_NN ._SENT Antimicrobial_JJ agents_NNS and_CC MIC_JJ determinations_NNS ._SENT |_SYM The_DT antimicrobial_JJ agents_NNS were_VBD obtained_VBN in_IN the_DT form_NN of_IN standard_JJ laboratory_NN powders_NNS and_CC were_VBD used_VBN immediately_RB after_IN their_PP$ solubilization_NN ._SENT The_DT agents_NNS and_CC their_PP$ sources_NNS have_VBP been_VBN described_VBN previously_RB ._SENT Antibiotic_JJ disks_NNS were_VBD used_VBN for_IN routine_JJ antibiograms_NNS (_( Sanofi_NP Diagnostics_NP Pasteur_NP ,_, Marnes-la-Coquette_NP ,_, France_NP )_) ._SENT MICs_NNS of_IN selected_JJ beta-lactams_NNS were_VBD determined_VBN by_IN an_DT agar_NN dilution_NN technique_NN on_IN Mueller-Hinton_NP plates_NNS (_( Sanofi_NP Diagnostics_NP Pasteur_NP )_) with_IN an_DT inoculum_NN of_IN 104_CD CFU_NN per_IN spot_NN ,_, as_RB described_VBN previously_RB ._SENT Cloning_VBG and_CC analysis_NN of_IN recombinant_JJ plasmids_NNS ._SENT |_SYM Whole-cell_NN DNA_NN of_IN C._NP gleum_NP CIP103039_NP was_VBD extracted_VBN as_IN described_VBN previously_RB ._SENT All_DT enzymes_NNS used_VBN in_IN cloning_VBG experiments_NNS were_VBD from_IN Amersham_NP Pharmacia_NP Biotech_NP (_( Orsay_NP ,_, France_NP )_) ._SENT Fragments_NNS from_IN whole-cell_NN DNA_NN partially_RB digested_VBN with_IN Sau3AI_NP were_VBD ligated_VBN into_IN BamHI-restricted_JJ phagemid_NN pBK-CMV_NP (_( Stratagene_NP ,_, Amsterdam_NP ,_, The_DT Netherlands_NPS )_) ,_, as_RB previously_RB reported_VBN ._SENT Ligations_NNS were_VBD performed_VBN at_IN a_DT 1:5_CD vector/insert_NN ratio_NN ,_, in_IN 30_CD mul_NN of_IN a_DT ligation_NN mixture_NN containing_VBG 5_CD U_NN of_IN T4_NP DNA_NP ligase_NN at_IN 4C_JJ incubated_VBN overnight_JJ ._SENT Recombinant_JJ plasmids_NNS were_VBD transformed_VBN by_IN electroporation_NN (_( Gene_NP Pulser_NP II_NP ;_: Bio-Rad_NP ,_, Ivry-sur-Seine_NP ,_, France_NP )_) into_IN E._NP coli_NNS DH10B_NP electrocompetent_NN cells_NNS (_( Gibco_NP BRL_NP ,_, Life_NP Technologies_NPS ,_, Cergy_NP Pontoise_NP ,_, France_NP )_) ._SENT Antibiotic-resistant_JJ colonies_NNS were_VBD selected_VBN onto_IN amoxicillin_NN (_( 30_CD mug/ml)-_NN and_CC kanamycin_NN (_( 30_CD mug/ml)-containing_NN TS_NP agar_NN plates_NNS ,_, and_CC their_PP$ antibiotic_JJ resistance_NN patterns_NNS were_VBD analyzed_VBN according_VBG to_TO the_DT results_NNS of_IN antibiogram_NN performed_VBN by_IN disk_NN diffusion_NN ._SENT Recombinant_JJ plasmid_NP DNAs_NP were_VBD obtained_VBN from_IN 100-ml_JJ TS_NP broth_NN cultures_NNS grown_VBN overnight_RB in_IN the_DT presence_NN of_IN amoxicillin_NN (_( 30_CD mug/ml_NN )_) at_IN 37C_JJ ._SENT Plasmid_NP DNAs_NP were_VBD recovered_VBN by_IN using_VBG Qiagen_NP (_( Courtaboeuf_NP ,_, France_NP )_) columns_NNS ._SENT Plasmid_NP mapping_NN were_VBD performed_VBN after_IN double-restriction_NN analysis_NN ._SENT Fragment_NN sizes_NNS were_VBD estimated_VBN by_IN comparison_NN with_IN the_DT 1-kb_JJ DNA_NN ladder_NN (_( Amersham_NP Pharmacia_NP Biotech_NP )_) ._SENT One_CD recombinant_JJ E._NP coli_NNS strain_NN that_WDT had_VBD reduced_VBN susceptibility_NN to_TO imipenem_NN and_CC harbored_VBD recombinant_JJ plasmid_NN pCGB-1_NN with_IN the_DT smallest_JJS 2-kb_JJ insert_NN was_VBD retained_VBN for_IN further_JJR analysis_NN ._SENT Plasmid_NP content_NN ,_, conjugation_NN assay_NN ,_, and_CC Southern_NP hybridization_NN ._SENT |_SYM Extraction_NP of_IN plasmid_NP DNA_NP from_IN C._NP gleum_NN CIP_NP 106039_CD and_CC direct_JJ transfer_NN by_IN conjugation_NN of_IN any_DT beta-lactam_NN resistance_NN marker_NN into_IN in_IN vitro-obtained_JJ nalidixic_JJ acid-resistant_JJ E._NP coli_NNS JM109_NP were_VBD attempted_VBN as_IN previously_RB described_VBN ._SENT Southern_JJ hybridization_NN was_VBD performed_VBN as_IN previously_RB described_VBN with_IN whole-cell_NN DNA_NN of_IN C._NP gleum_NN CIP_NP 103039_CD by_IN using_VBG the_DT enhanced_JJ chemiluminescence_NN nonradioactive_NN labeling_VBG and_CC detection_NN kit_NN (_( Amersham_NP Pharmacia_NP Biotech_NP )_) with_IN a_DT 628-bp_JJ PCR-obtained_JJ probe_NN with_IN primers_NNS internal_JJ to_TO blaCGB-1_JJ (_( primer_NN 1_CD :_: 5'-GCAAACGCCCGGATACAACAG-3_NN '_'' ;_: primer_NN 2_CD ;_: 5'-TTCCATTCATCATGTCCGGG-3_NP '_POS )_) beta-Lactamase_NN purification_NN ._SENT |_SYM A_DT culture_NN of_IN E._NP coli_NNS DH10B_NP harboring_VBG recombinant_JJ plasmid_NN pCGB-1_NN was_VBD grown_VBN overnight_RB at_IN 37C_JJ in_IN 4_CD liters_NNS of_IN TS_NP broth_NN containing_VBG amoxicillin_NN (_( 30_CD mug/ml_NN )_) ._SENT Bacterial_JJ suspensions_NNS were_VBD pelleted_VBN ,_, resuspended_VBN in_IN 60_CD ml_NN of_IN 30_CD mM_NP Tris-HCl_NP buffer_NN (_( pH_NN 8.2_CD )_) ,_, disrupted_VBN by_IN sonification_NN (_( three_CD times_NNS at_IN 30_CD W_NN for_IN 30_CD s_NNS with_IN a_DT Vibra_NP Cell_NP 75022_CD Phospholyser_NN [_SYM Bioblock_NP ,_, Illkirch_NP ,_, France_NP ]_SYM )_) ,_, and_CC centrifuged_VBD for_IN 1_CD h_NN at_IN 48,000_CD x_NN g_NN at_IN 4C_JJ ._SENT the_DT supernatant_JJ ultracentrifuged_NN at_IN 100,000_CD x_NN g_NN for_IN 1_CD h_NN at_IN 4C_JJ and_CC the_DT supernatant_JJ was_VBD dialyzed_VBN overnight_RB against_IN 30_CD mM_NP Tris-HCl_NP buffer_NN (_( pH_NN 8.2_CD )_) ._SENT This_DT extract_NN was_VBD loaded_VBN onto_IN a_DT preequilibrated_JJ Q-Sepharose_NP column_NN (_( Amersham_NP Pharmacia_NP Biotech_NP )_) ._SENT The_DT enzyme_NN recovered_VBD in_IN the_DT flowthrough_NN and_CC determined_VBN qualitatively_RB by_IN nitrocefin_NN hydrolysis_NN (_( Oxoid_NP ,_, Dardilly_NP ,_, France_NP )_) was_VBD dialyzed_VBN overnight_RB at_IN 4C_JJ against_IN 50_CD mM_NP sodium_NN phosphate_NN buffer_NN (_( pH_NN 7.0_CD )_) ._SENT The_DT beta-lactamase_NN extract_NN was_VBD then_RB loaded_VBN onto_IN a_DT preequilibrated_JJ S-Sepharose_NP column_NN (_( Amersham_NP Pharmacia_NP Biotech_NP )_) preequilibrated_VBD with_IN the_DT same_JJ buffer_NN ._SENT The_DT enzyme_NN was_VBD eluted_VBN by_IN a_DT 100-ml_JJ linear_JJ NaCl_NP gradient_NN (_( 0_CD to_TO 500_CD mM_NNS )_) in_IN sodium_NN phosphate_NN buffer_NN (_( pH_NN 7.0_CD )_) ._SENT The_DT beta-lactamase_NN was_VBD eluted_VBN at_IN a_DT concentration_NN of_IN 260_CD mM_NP NaCl_NP ._SENT The_DT fractions_NNS containing_VBG the_DT highest_JJS beta-lactamase_NN activities_NNS were_VBD pooled_VBN ,_, dialyzed_VBN overnight_RB against_IN 50_CD mM_NP sodium_NN phosphate_NN buffer_NN (_( pH_NN 7.0_CD )_) containing_VBG 50_CD muM_NN ZnCl2_NN and_CC stored_VBD at_IN -80C_NN ._SENT Purity_NN of_IN the_DT enzyme_NN was_VBD estimated_VBN by_IN sodium_NN dodecyl_NN sulfate-polyacrylamide_NN gel_NN electrophoresis_NN (_( SDS-PAGE_NP )_) ._SENT IEF_NN analysis_NN and_CC N-terminal_NP sequencing_NP ._SENT |_SYM Purified_JJ enzyme_NN preparation_NN from_IN culture_NN of_IN E._NP coli_NNS DH10B_NP harboring_VBG pCGB-1_JJ and_CC beta-lactamase_JJ crude_NN extracts_VBZ from_IN 100_CD ml-culture_NN of_IN C._NP gleum_NN CIP_NP 103039_CD were_VBD subjected_VBN to_TO analytical_JJ isoelectric_JJ focusing_VBG (_( IEF_NP )_) on_IN a_DT pH_NN 3.5_CD to_TO 9.5_CD ampholine_NN polyacrylamide_NN gel_NN (_( Ampholin_NP PAG_NP plate_NN ;_: Amersham_NP Pharmacia_NP Biotech_NP )_) as_RB described_VBD previously_RB ._SENT In_IN order_NN to_TO determine_VB the_DT cleavage_NN site_NN of_IN the_DT CGB-1_JJ mature_JJ protein_NN ,_, the_DT purified_VBN enzyme_NN was_VBD subjected_VBN to_TO an_DT Edman_NP analysis_NN at_IN the_DT laboratory_NN for_IN protein_NN microsequencing_NN at_IN the_DT Pasteur_NP Institute_NP ,_, Paris_NP ,_, France_NP ._SENT Purified_VBN enzyme_NN and_CC marker_NN proteins_NNS were_VBD subjected_VBN to_TO SDS-PAGE_NP (_( 25_CD mA_NNS ,_, 4_CD h_NN ,_, room_NN temperature_NN )_) ._SENT Proteins_NNS were_VBD then_RB electrotransferred_VBN onto_IN a_DT polyvinyl_NN difluoride_NN membrane_NN (_( Immobilon-P_NP ;_: Millipore_NP )_) by_IN using_VBG the_DT Mini_NP Protean_NP II_NP transfer_NN cell_NN (_( 8_CD by_IN 7.3_CD cm_NN ;_: Bio-Rad_NP )_) in_IN 50_CD mM_NP Tris-borate_NN buffer_NN (_( pH_NN 8.7_CD )_) at_IN room_NN temperature_NN (_( 3.5_CD V/cm_NP ,_, overnight_JJ )_) ._SENT The_DT membrane_NN was_VBD then_RB rinsed_VBN in_IN distilled_JJ water_NN and_CC stained_VBN with_IN a_DT solution_NN made_VBN of_IN 0.1_CD %_NN Coomassie_NP brilliant_JJ blue_JJ R-250_NN in_IN methanol_NN and_CC water_NN (_( 50:40_CD [_SYM vol/vol_NN ]_SYM )_) ._SENT The_DT protein_NN band_NN was_VBD then_RB excised_VBN with_IN a_DT razor_NN blade_NN and_CC allowed_VBD to_TO air_VB dry_JJ ._SENT The_DT amino-terminal_JJ sequence_NN of_IN the_DT mature_JJ beta-lactamase_NN was_VBD determined_VBN with_IN an_DT automated_JJ Edman_NP sequencer_NN on_IN a_DT 473A_JJ model_NN gas_NN phase_NN sequencer_NN (_( Applied_NP Biosystems_NP )_) ._SENT Kinetic_JJ measurements_NNS of_IN beta-lactamase_NN CGB-1_NN and_CC induction_NN study_NN ._SENT |_SYM C._NP gleum_NP CIP103039_NP crude_JJ extract_NN was_VBD used_VBN to_TO detect_VB imipenem_NN hydrolysis_NN in_IN preliminary_JJ experiments_NNS ._SENT Purified_VBN metallo-beta-lactamase_NN CGB-1_NN was_VBD used_VBN for_IN kinetic_JJ measurements_NNS performed_VBN at_IN 30C_JJ in_IN 100_CD mM_NP sodium_NN phosphate_NN (_( pH_NN 7.0_CD )_) containing_VBG 50_CD muM_NN ZnCl2_NP ._SENT Determinations_NNS of_IN specific_JJ activities_NNS of_IN purified_VBN enzyme_NN and_CC of_IN beta-lactamase_NN extract_NN from_IN C._NP gleum_NN CIP_NP 103039_CD were_VBD performed_VBN with_IN 100_CD muM_NN imipenem_NN as_IN a_DT substrate_NN as_RB described_VBD previously_RB ._SENT The_DT total_JJ protein_NN content_NN was_VBD measured_VBN with_IN bovine_JJ albumin_NN as_IN the_DT standard_JJ (_( Bio-Rad_NP DC_NP protein_NN assay_NN kit_NN )_) ._SENT Km_NN and_CC kcat_NN values_NNS were_VBD determined_VBN with_IN a_DT spectrophotometer_NN ULTROSPEC_NP 2000_CD (_( Amersham_NP Pharmacia_NP Biotech_NP )_) by_IN analyzing_VBG the_DT beta-lactam_NN hydrolysis_NN under_IN initial_JJ rate_NN conditions_NNS by_IN using_VBG the_DT Eadie-Hofstee_NP linearization_NN of_IN the_DT Michaelis-Menten_NP equation_NN as_IN previously_RB described_VBN previously_RB ._SENT Various_JJ concentrations_NNS of_IN EDTA_NP and_CC clavulanic_JJ acid_NN were_VBD preincubated_VBN with_IN the_DT enzyme_NN for_IN 3_CD min_NN at_IN 30C_JJ before_IN testing_VBG the_DT rate_NN of_IN imipenem_NN hydrolysis_NN ._SENT Fifty_CD percent_NN inhibitory_JJ concentrations_NNS (_( IC50s_NP )_) were_VBD determined_VBN for_IN EDTA_NP and_CC clavulanic_JJ acid_NN ,_, and_CC results_NNS were_VBD expressed_VBN in_IN micromolar_JJ units_NNS ._SENT Induction_NN experiments_NNS were_VBD performed_VBN with_IN 1_CD and_CC 4_CD mug_NN of_IN cefoxitin_NN per_IN ml_NN and_CC 0.1_CD mug_NN of_IN imipenem_NN per_IN ml_NN as_IN inducer_NN with_IN cultures_NNS of_IN C._NP gleum_NN CIP_NP 103039_CD and_CC E._NP coli_NNS DH10B(pCGB-1)_NP ,_, as_RB previously_RB described_VBN ._SENT DNA_NP sequencing_NP and_CC protein_NN analysis_NN ._SENT |_SYM The_DT cloned_VBN DNA_NN fragment_NN of_IN recombinant_JJ plasmids_NNS pCGB-1_NN was_VBD sequenced_VBN on_IN both_DT strands_NNS ,_, with_IN an_DT Applied_NP Biosystems_NP sequencer_NN (_( ABI_NP 377_CD )_) ._SENT The_DT nucleotide_NN and_CC the_DT deduced_VBN protein_NN sequences_NNS were_VBD analyzed_VBN with_IN software_NN available_JJ over_IN the_DT Internet_NN as_RB reported_VBD previously_RB ._SENT The_DT relative_JJ molecular_JJ mass_NN of_IN the_DT beta-lactamase_NN expressed_VBN by_IN a_DT culture_NN of_IN E._NP coli_NNS DH10B(pCGB-1)_NP was_VBD estimated_VBN by_IN SDS-PAGE_NP analysis_NN ,_, as_RB previously_RB described_VBN ._SENT Nucleotide_NN sequence_NN accession_NN number_NN ._SENT |_SYM The_DT nucleotide_NN sequence_NN and_CC deduced_VBD beta-lactamase_JJ amino_NN acid_NN sequence_NN reported_VBD in_IN this_DT work_NN have_VBP been_VBN assigned_VBN to_TO the_DT GenBank_NP and_CC EMBL_NP databases_NNS under_IN the_DT accession_NN no_RB ._SENT ._SENT Cloning_VBG experiments_NNS ._SENT |_SYM Preliminary_JJ experiments_NNS of_IN imipenem_NN hydrolysis_NN with_IN a_DT beta-lactamase_NN extract_NN of_IN C._NP gleum_NN CIP_NP 103039_CD suggested_VBD the_DT presence_NN of_IN a_DT carbapenem-hydrolyzing_NN beta-lactamase_NN in_IN addition_NN to_TO a_DT previously_RB characterized_VBN class_NN A_DT beta-lactamase_NN ._SENT Forty_NN recombinant_JJ E._NP coli_NNS DH10B_NP clones_NNS harboring_VBG plasmids_NNS with_IN inserts_NNS that_WDT varied_VBD in_IN size_NN (_( 2.0_CD to_TO 10_CD kb_NN )_) were_VBD obtained_VBN after_IN shotgun_NN cloning_VBG of_IN Sau3AI-restricted_NP DNA_NP of_IN C._NP gleum_NN CIP_NP 103039_CD ._SENT Among_IN them_PP ,_, 28_CD clones_NNS had_VBD decreased_VBN susceptibility_NN to_TO ceftazidime_NN and_CC a_DT beta-lactam_NN resistance_NN phenotype_NN that_WDT was_VBD susceptible_JJ to_TO clavulanic_JJ acid_NN inhibition_NN that_WDT was_VBD consistent_JJ with_IN the_DT presence_NN of_IN the_DT previously_RB characterized_VBN class_NN A_DT enzyme_NN CGA-1_NN ._SENT Twelve_CD other_JJ recombinant_JJ E._NP coli_NNS clones_NNS had_VBD a_DT slight_JJ decrease_NN of_IN susceptibility_NN to_TO carbapenems_NNS ._SENT Among_IN them_PP ,_, E._NP coli_NNS DH10B(pCGB-1)_NP harboring_VBG a_DT recombinant_JJ plasmid_NN which_WDT possessed_VBD the_DT smallest_JJS 2.0-kb_JJ insert_NN was_VBD retained_VBN ._SENT DNA_NN and_CC protein_NN sequence_NN analysis_NN of_IN CGB-1_NP ._SENT |_SYM DNA_NP sequence_NN analysis_NN of_IN the_DT 2,004-bp_JJ insert_NN of_IN pCGB-1_NN revealed_VBD an_DT open_JJ reading_NN frame_NN (_( ORF_NP )_) (_( named_VBN blaCGB-1_NN )_) of_IN 729_CD bp_NN (_( from_IN nucleotide_NN 461_CD to_TO 1,189_CD )_) encoding_VBG a_DT 243-amino-acid_JJ preprotein_NN ._SENT A_DT putative_JJ cleavage_NN site_NN was_VBD found_VBN by_IN computer_NN analysis_NN after_IN the_DT Ala-Asn-Ala_NP motif_NN ._SENT N-terminal_JJ sequence_NN analysis_NN of_IN the_DT protein_NN confirmed_VBD that_IN the_DT first_JJ amino_NN acids_NNS residues_NNS of_IN the_DT mature_JJ protein_NN were_VBD QDTQ_NP ._SENT The_DT resulting_VBG mature_JJ protein_NN contained_VBD 223_CD amino_NN acid_NN residues_NNS ._SENT The_DT overall_JJ G+C_NP content_NN of_IN this_DT ORF_NP was_VBD 36_CD %_NN ,_, which_WDT lies_VBZ within_IN the_DT expected_VBN range_NN of_IN G+C_NP ratio_NN of_IN the_DT Chryseobacterium_NN genes_NNS (_( 36_CD to_TO 38_CD %_NN )_) ._SENT Another_DT truncated_JJ ORF_NP was_VBD detected_VBN on_IN this_DT same_JJ insert_NN (_( nucleotide_NN 1,240_CD to_TO 2,004_CD )_) of_IN recombinant_JJ plasmid_NN pCGB-1_NN located_VBN downstream_IN and_CC in_IN opposite_JJ orientation_NN of_IN blaCGB-1_NN ._SENT It_PP encoded_VBD 254_CD amino_NN acids_NNS of_IN the_DT carboxyl_NN end_NN of_IN a_DT putative_JJ protein_NN that_WDT possessed_VBD 31.5_CD %_NN amino_NN acid_JJ identity_NN with_IN the_DT capreomycin_NN acetyltransferase_NN from_IN Streptomyces_NP capreolus_NP (_( accession_NN number_NN no_RB ._SENT )_) ._SENT A_DT similar_JJ capreomycin_NN resistance_NN gene_NN had_VBD been_VBN identified_VBN downstream_RB and_CC in_IN opposite_JJ orientation_NN of_IN the_DT class_NN B_NN beta-lactamase_NN gene_NN blaIND-1_NN from_IN C._NP indologenes_NNS 001_CD (_( unpublished_JJ data_NNS )_) and_CC in_IN Mycobacterium_NN tuberculosis_NN genome_NN (_( accession_VB no_RB ._SENT )_) ._SENT Thus_RB ,_, the_DT blaCGB-1_JJ gene_NN may_MD be_VB part_NN of_IN a_DT cluster_NN of_IN antibiotic_JJ resistance_NN genes_NNS ._SENT A_DT putative_JJ DNA_NN sequence_NN ,_, located_VBN from_IN nucleotides_NNS 1,187_CD to_TO 1,229_CD between_IN the_DT stop_NN codon_NN of_IN blaCGB-1_NN and_CC the_DT stop_NN codon_NN of_IN the_DT putative_JJ capreomycin_NN acetyltransferase_NN gene_NN ,_, might_MD play_VB a_DT role_NN as_IN a_DT transcription_NN terminator_NN ._SENT Genetic_JJ location_NN of_IN blaCGB-1_NN ._SENT |_SYM No_NP plasmid_NP was_VBD detected_VBN in_IN C._NP gleum_NN CIP_NP 103039_CD ,_, and_CC direct_JJ conjugation_NN experiments_NNS failed_VBD to_TO transfer_VB any_DT beta-lactam_NN resistance_NN marker_NN from_IN C._NP gleum_NN CIP_NP 103039_CD to_TO nalidixic_JJ acid-resistant_JJ E._NP coli_NNS JM109_NP ._SENT Using_VBG an_DT internal_JJ probe_NN for_IN blaCGB-1_JJ ,_, Southern_JJ hybridization_NN was_VBD positive_JJ at_IN the_DT chromosomal_JJ position_NN of_IN migration_NN of_IN whole-cell_NN DNA_NN of_IN C._NP gleum_NN CIP_NP 103039_CD (_( data_NNS not_RB shown_VBN )_) Susceptibility_NN testing_NN ._SENT |_SYM MICs_NP of_IN beta-lactams_NNS for_IN C._NP gleum_NN CIP_NP 103039_CD showed_VBD that_IN it_PP was_VBD resistant_JJ to_TO amino-_NN and_CC carboxy-penicillins_NNS ,_, narrow-spectrum_NN cephalosporins_NNS ,_, cefotaxime_NN ,_, aztreonam_NP ,_, had_VBD intermediate_JJ susceptibility_NN to_TO carbapenems_NNS and_CC remained_VBD susceptible_JJ to_TO piperacillin_NN ._SENT E._NP coli_NNS DH10B(pCGB-1)_NP was_VBD resistant_JJ to_TO amoxicillin_NN ,_, ticarcillin_NP ,_, some_DT restricted-spectrum_NN cephalosporins_NNS ,_, and_CC had_VBD a_DT reduced_VBN susceptibility_NN to_TO piperacillin_NN ,_, ceftazidime_NN and_CC carbapenems_NNS compared_VBN to_TO that_DT of_IN E._NP coli_NNS DH10B_NP ._SENT MICs_NNS of_IN beta-lactams_NNS for_IN E._NP coli_NNS DH10B(pCGB-1)_NP were_VBD not_RB lowered_VBN by_IN addition_NN of_IN clavulanic_JJ acid_NN and_CC tazobactam_NN ._SENT Resistance_NN to_TO aztreonam_NP in_IN C._NP gleum_NP CIP103039_NP as_RB found_VBD in_IN other_JJ flavobacterial_JJ species_NNS (_( -_: )_) may_MD be_VB partially_RB explained_VBN by_IN expression_NN of_IN the_DT previously_RB characterized_VBN clavulanic_JJ acid-inhibited_JJ CGA-1_JJ enzyme_NN ._SENT Other_JJ resistance_NN mechanisms_NNS such_JJ as_IN low_JJ outer_JJ membrane_NN permeability_NN ,_, efflux_NN ,_, and_CC penicillin_NN binding_JJ protein_NN affinity_NN may_MD explain_VB also_RB resistance_NN to_TO this_DT compound_NN ._SENT Once_RB cloned_VBN onto_IN a_DT plasmid_NP vector_NN and_CC expressed_VBN in_IN E._NP coli_NNS ,_, both_CC enzymes_NNS ,_, CGB-1_NP and_CC IND-1_NP ,_, provided_VBD a_DT similar_JJ pattern_NN of_IN decreased_VBN susceptibility_NN to_TO beta-lactams_NNS ,_, although_IN in_IN the_DT latter_JJ case_NN the_DT degree_NN of_IN resistance_NN was_VBD more_RBR important_JJ ._SENT The_DT overall_JJ susceptibility_NN of_IN C._NP gleum_NN to_TO beta-lactams_NNS was_VBD similar_JJ to_TO that_WDT reported_VBD for_IN C._NP meningosepticum_NN ._SENT As_RB for_IN C._NP meningosepticum_NN that_WDT possesses_VBZ a_DT class_NN A_DT beta-lactamase_NN (_( CME_NP )_) and_CC two_CD class_NN B_NN beta-lactamases_NNS (_( BlaB_NP and_CC GOB_NP )_) ,_, C._NP gleum_NP possesses_VBZ ,_, in_IN addition_NN to_TO the_DT class_NN A_DT beta-lactamase_NN CGA-1_NP ,_, another_DT very_RB likely_JJ chromosomal-encoded_JJ class_NN B_NN enzyme_NN CGB-1_NP ._SENT Biochemical_JJ properties_NNS of_IN CGB-1_NP ._SENT |_SYM IEF_NP analysis_NN revealed_VBD that_IN cultures_NNS of_IN E._NP coli_NNS DH10B(pCGB-1)_NP produced_VBD a_DT beta-lactamase_NN activity_NN with_IN a_DT pI_NN value_NN of_IN 8.6_CD ._SENT However_RB ,_, only_RB one_CD beta-lactamase_NN activity_NN was_VBD detected_VBN from_IN crude_NN extracts_VBZ of_IN a_DT culture_NN of_IN C._NP gleum_NP CIP103039_NP ,_, at_IN a_DT pI_NN of_IN 8.9_CD that_WDT corresponded_VBD to_TO the_DT previously_RB identified_VBN class_NN A_DT beta-lactamase_NN CGA-1_NN ._SENT Thus_RB ,_, expression_NN of_IN CGB-1_NP from_IN C._NP gleum_NN CIP_NP 103039_CD might_MD be_VB weak_JJ ._SENT The_DT specific_JJ activity_NN of_IN the_DT purified_VBN CGB-1_JJ enzyme_NN was_VBD 8.3_CD mumolmin-1mg_NN of_IN protein-1_NN ,_, determined_VBN with_IN 100_CD muM_NN imipenem_NN as_IN a_DT substrate_NN with_IN a_DT 174-fold_NN purification_NN coefficient_NN ._SENT Its_PP$ purity_NN was_VBD estimated_VBN to_TO be_VB 95_CD %_NN by_IN SDS-PAGE_NP (_( data_NN not_RB shown_VBN )_) ._SENT The_DT mature_JJ protein_NN (_( named_VBN CGB-1_NP for_IN C._NP gleum_NN class_NN B_NP beta-lactamase_NN )_) expressed_VBN in_IN E._NP coli_NNS DH10B_NP had_VBD a_DT relative_JJ molecular_JJ mass_NN determined_VBN experimentally_RB to_TO be_VB ca_MD ._SENT 26_CD kDa_NN (_( data_NNS not_RB shown_VBN )_) ._SENT Kinetic_JJ parameters_NNS of_IN CGB-1_NP revealed_VBD a_DT strong_JJ activity_NN against_IN amino-_NN and_CC carboxy-penicillins_NNS and_CC restricted-spectrum_NN cephalosporins_NNS ._SENT Surprisingly_RB ,_, cefotaxime_NN was_VBD a_DT good_JJ substrate_NN for_IN CGB-1_NP due_JJ to_TO a_DT low_JJ Km_NP ,_, whereas_IN ceftazidime_NN that_WDT possesses_VBZ a_DT Km_NP superior_NN to_TO 1_CD mM_NNS was_VBD a_DT very_RB poor_JJ substrate_NN ._SENT This_DT difference_NN in_IN hydrolysis_NN activity_NN mirrored_VBD the_DT MICs_NN for_IN both_DT beta-lactams_NNS for_IN C._NP gleum_NN CIP_NP 103039_CD (_( but_CC not_RB for_IN E._NP coli_NNS DH10B(pCGB-1)_NP ._SENT CGB-1_JJ beta-lactamase_NN had_VBD poor_JJ affinity_NN for_IN imipenem_NN (_( Km_NP ,_, >1,000_NN muM_NN )_) ,_, resulting_VBG in_IN a_DT weak_JJ catalytic_JJ efficacy_NN of_IN imipenem_NN ._SENT Therefore_RB ,_, its_PP$ kcat/Km_NN value_NN for_IN imipenem_NN was_VBD at_IN least_JJS 10-fold_JJ lower_JJR than_IN that_DT of_IN IND-2_NP ,_, whereas_IN these_DT values_NNS for_IN meropenem_NN and_CC for_IN benzylpenicillin_NN were_VBD only_RB twofold_RB lower_JJR ._SENT These_DT results_NNS were_VBD consistent_JJ with_IN the_DT low_JJ level_NN of_IN resistance_NN to_TO imipenem_NN of_IN C._NP gleum_NN CIP_NP 103039_CD ._SENT Hydrolysis_NN of_IN aztreonam_NP was_VBD not_RB detectable_JJ ,_, as_RB found_VBN for_IN all_DT metallo-enzymes_NNS ._SENT Catalytic_JJ efficacy_NN of_IN CGB-1_NP was_VBD lower_JJR than_IN that_DT of_IN GOB-1_NP from_IN C._NP meningosepticum_NN for_IN all_DT beta-lactams_NNS except_IN for_IN benzylpenicillin_NN which_WDT were_VBD similar_JJ ._SENT CGB-1_NP had_VBD kcat/Km_NN values_NNS which_WDT were_VBD 4-fold_NN lower_JJR for_IN benzylpenicillin_NN ,_, 10-fold_NN lower_JJR for_IN cephaloridine_NN and_CC for_IN cefoxitin_NN ,_, 60-fold_NN lower_JJR for_IN imipenem_NN ,_, and_CC 3-fold_JJ higher_JJR for_IN cefotaxime_NN ,_, compared_VBN to_TO those_DT of_IN BlaB_NP from_IN C._NP meningosepticum_NN ._SENT The_DT hydrolytic_JJ activity_NN of_IN CGB-1_NP was_VBD inhibited_VBN by_IN EDTA_NP (_( IC50_NP ,_, 37_CD muM_NN )_) but_CC not_RB by_IN class_NN A_DT beta-lactamase_NN inhibitors_NNS such_JJ as_IN clavulanic_JJ acid_NN (_( IC50_NP >_SYM 1_CD mM_NNS )_) ._SENT These_DT kinetic_JJ parameters_NNS lead_VBP to_TO include_VB CGB-1_NP in_IN the_DT biochemical_JJ group_NN 3a_NN of_IN the_DT Bush_NP beta-lactamase_NN classification_NN for_IN metallo-enzymes_NNS ._SENT This_DT group_NN includes_VBZ all_DT characterized_VBN metallo-beta-lactamases_NNS with_IN a_DT very_RB broad_JJ substrate_NN hydrolysis_NN profile_NN except_IN FEZ-1_NP and_CC Cph-A-like_JJ enzymes_NNS from_IN L._NP gormanii_NP and_CC Aeromonas_NP sp_NN ._SENT ,_, respectively_RB ._SENT Induction_NN experiments_NNS ._SENT |_SYM Induction_NN studies_NNS with_IN cefoxitin_NN and_CC imipenem_NN as_IN beta-lactam_NN inducers_NNS failed_VBD to_TO detect_VB induction_NN of_IN beta-lactamase_NN expression_NN with_IN cultures_NNS of_IN C._NP gleum_NN CIP_NP 103039_CD and_CC of_IN E._NP coli(pCGB-1)_NN with_IN imipenem_NN as_IN substrate_NN ._SENT These_DT results_NNS are_VBP consistent_JJ with_IN the_DT absence_NN of_IN any_DT sequence_NN for_IN regulatory_JJ gene_NN ,_, such_JJ as_IN LysR-type_NP regulator_NN gene_NN upstream_RB of_IN blaCGB-1_NN ._SENT Amino_NN acid_NN sequence_NN analysis_NN ._SENT |_SYM The_DT comparison_NN of_IN amino_NN acid_NN sequence_NN of_IN CGB-1_NP with_IN those_DT of_IN other_JJ class_NN B_NN beta-lactamases_NNS revealed_VBD 83_CD %_NN identity_NN with_IN IND-1_NP ,_, 82_CD %_NN identity_NN with_IN IND-2_NP and_CC IND-3_NP ,_, and_CC 73_CD %_NN identity_NN with_IN IND-4_NP from_IN C._NP indologenes_NNS ,_, and_CC only_RB 42_CD and_CC 12_CD %_NN identity_NN with_IN BlaB_NP and_CC GOB-1_NP from_IN C._NP meningosepticum_NN ,_, respectively_RB (_( -_: ,_, )_) ._SENT Thus_RB ,_, the_DT metallo-enzyme_NN of_IN C._NP gleum_NN was_VBD most_RBS closely_RB related_VBN to_TO those_DT of_IN C._NP indologenes_NNS thus_RB paralleling_VBG the_DT taxonomic_JJ position_NN of_IN both_DT Chryseobacterium_NN species_NN ._SENT The_DT six_CD conserved_VBN amino_NN acid_NN residues_NNS implicated_VBN in_IN the_DT Zn2+_NP or_CC water_NN molecule_NN binding_VBG (_( His116_NP ,_, His118_NP ,_, Asp120_NP ,_, His196_NP ,_, Cys221_NP ,_, and_CC His_PP$ 220_CD )_) of_IN metallo-beta-lactamases_NNS were_VBD found_VBN in_IN the_DT CGB-1_JJ sequence_NN ._SENT However_RB ,_, an_DT insertion_NN of_IN three_CD amino_NN acids_NNS (_( Asp_NP ,_, Thr_NP ,_, and_CC Gln_NP )_) was_VBD detected_VBN at_IN the_DT second_JJ ,_, third_JJ and_CC fourth_JJ position_NN of_IN the_DT N-terminal_JJ sequence_NN of_IN the_DT mature_JJ protein_NN CGB-1_NN (_( positions_NNS 22_CD ,_, 23_CD ,_, and_CC 24_LS )_) compared_VBN to_TO IND-like_JJ ._SENT beta-Lactamase_NP CGB-1_NP may_MD be_VB classified_VBN in_IN the_DT molecular_JJ subclass_NN B1_NN of_IN the_DT structural_JJ classification_NN that_IN groups_NNS IND-like_JJ ,_, Bc-II_NP ,_, CfiA_NP ,_, BlaB_NP ,_, IMP_NP ,_, and_CC VIM_NP beta-lactamases_NNS ._SENT A_DT phylogenic_JJ analysis_NN of_IN CGB-1_NP from_IN C._NP gleum_NP ,_, BlaB_NP variants_NNS from_IN C._NP meningosepticum_NN (_( and_CC not_RB GOB_NP variants_NNS from_IN C._NP meningosepticum_NN also_RB )_) ,_, and_CC IND_JJ variants_NNS from_IN C._NP indologenes_NNS ,_, showed_VBD that_IN they_PP belong_VBP to_TO a_DT same_JJ phylogenic_JJ lineage_NN (_( data_NNS not_RB shown_VBN )_) ._SENT Comparison_NN of_IN amino_NN acid_NN sequence_NN of_IN CGB-1_NP with_IN those_DT of_IN IND-1_NP and_CC IND-2_NP did_VBD not_RB provide_VB evidence_NN of_IN any_DT particular_JJ amino_NN acid_NN residue_NN that_WDT may_MD explain_VB a_DT lower_JJR affinity_NN of_IN CGB-1_NP for_IN carbapenems_NNS ._SENT In_IN conclusion_NN ,_, this_DT report_NN identified_VBD a_DT novel_JJ bacterial_JJ species_NNS for_IN which_WDT beta-lactam_NN resistance_NN is_VBZ at_IN least_JJS mediated_VBN by_IN an_DT Ambler_NP class_NN A_DT expanded-spectrum_NN beta-lactamase_NN and_CC an_DT Ambler_NP class_NN B_NN metallo-enzyme_NN ,_, as_RB found_VBN in_IN S._NP maltophilia_NP and_CC C._NP meningosepticum_NN ._SENT FIG._NN 1_CD ._SENT |_SYM Nucleotide_NN sequence_NN of_IN the_DT cloned_VBN 2,004-bp_JJ fragment_NN of_IN recombinant_JJ plasmid_NN pCGB-1_NN containing_VBG the_DT blaCGB-1_JJ coding_VBG region_NN and_CC a_DT truncated_JJ ORF_NP encoding_VBG a_DT putative_JJ capreomycin_NN resistance_NN determinant_NN ._SENT Nucleotide_NN sequence_NN of_IN the_DT cloned_VBN 2,004-bp_JJ fragment_NN of_IN recombinant_JJ plasmid_NN pCGB-1_NN containing_VBG the_DT blaCGB-1_JJ coding_VBG region_NN and_CC a_DT truncated_JJ ORF_NP encoding_VBG a_DT putative_JJ capreomycin_NN resistance_NN determinant_NN ._SENT The_DT deduced_VBN amino_NN acid_NN sequence_NN is_VBZ designated_VBN in_IN the_DT single-letter_NN code_NN below_IN the_DT nucleotide_NN sequence_NN ._SENT The_DT putative_JJ terminator_NN sequence_NN is_VBZ indicated_VBN by_IN two_CD inverted_JJ arrows_NNS ,_, and_CC stop_NN codons_NNS are_VBP indicated_VBN by_IN stars_NNS ._SENT FIG._NN 2_CD ._SENT |_SYM Comparison_NN of_IN the_DT amino_NN acid_NN sequence_NN of_IN beta-lactamase_NN CGB-1_NN with_IN those_DT of_IN IND-1_NP ,_, IND-2_NP ,_, IND-3_NP ,_, and_CC IND-4_NP from_IN C._NP indologenes_NNS Comparison_NN of_IN the_DT amino_NN acid_NN sequence_NN of_IN beta-lactamase_NN CGB-1_NN with_IN those_DT of_IN IND-1_NP ,_, IND-2_NP ,_, IND-3_NP ,_, and_CC IND-4_NP from_IN C._NP indologenes_NP and_CC BlaB_NP from_IN C._NP meningosepticum_NN ._SENT The_DT BBL_NP numbering_VBG scheme_NN is_VBZ indicated_VBN above_IN the_DT sequences_NNS ._SENT Broken_VBN lines_NNS and_CC dots_NNS indicated_VBD identical_JJ and_CC deleted_VBN amino_NN acid_NN residues_NNS ,_, respectively_RB ._SENT The_DT vertical_JJ arrow_NN indicates_VBZ the_DT putative_JJ cleavage_NN site_NN for_IN the_DT leader_NN peptide_NN of_IN CGB-1_NP ._SENT Amino_NN acids_NNS that_WDT may_MD be_VB involved_VBN in_IN binding_VBG of_IN Zn2+_NP or/and_NN water_NN are_VBP indicated_VBN by_IN a_DT star_NN ._SENT TABLE_NN 1_CD |_SYM MICs_NN of_IN beta-lactams_NNS for_IN C._NP gleum_NN CIP_NP 103039_CD ,_, E._NP coli_NNS DH10B(pCGB-1)_NP expressing_VBG CGB-1_NP ,_, E._NP coli_NNS DH10B(pSO-1)_NP expressing_VBG IND-1_NP from_IN C._NP indologenes_NP OO1_NP ,_, and_CC reference_NN strain_NN E._NP coli_NNS DH10B_NP TABLE_NP 2_CD |_SYM Kinetic_JJ parameters_NNS of_IN purified_VBN CGB-1_NN from_IN cultures_NNS of_IN E._NP coli_NNS DH10B(pCGB-1)_NP 